Results 281 to 290 of about 1,187,067 (387)

The Impact of Isotonic Seawater on Subjective and Objective Nose Patency in Athletes: A Randomized Controlled Trial. [PDF]

J Clin Med
Košec A, Vlahović T, Šilović B, Rakić M, Starešinić A, Aljinović-Vučić V.   +5 more
europepmc   +1 more source

A solitary erythematous papule on the nose

JAAD Case Reports, 2020
Soodeh Kabir, MD, Mehrdad Teimoorian, MD, Maryam Mahdavi, MD, Naser Tayyebi Meibodi, MD, Mahroo Tajalli, MD, Vahid Mashayekhi Goyonlo, MD, Sara Sabourirad, MD   +6 more
doaj  

Parental first aid literacy in epistaxis: do parents know what to do? [PDF]

Front Public Health
AlZabin A, Almajed E, AlTamimi R, Alqasimi NA, Albalawi Y, AlWehaibi N.   +5 more
europepmc   +1 more source

The Nose, Throat and Ear and Their Diseases

, 1930
NULL AUTHOR_ID
openalex   +1 more source

Elexacaftor–Tezacaftor–Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic Fibrosis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Severe chronic rhinosinusitis (CRS) is a near universal manifestation of cystic fibrosis. Elexacaftor/tezacaftor/ivacaftor (ETI) is an oral, small molecule, highly effective Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) corrector–potentiator drug.
Amanda L. Stapleton, Adam Kimple, Jennifer L. Goralski, Daniel M. Beswick, Anshika Gupta, Douglas A. Li, Barton F. Branstetter, S. Mehdi Nouraie, Amber D. Shaffer, Brent Senior, Anna C. Zemke   +10 more
wiley   +1 more source

High Concordance of E-Nose-Derived Breathprints in a Healthy Population: A Cross-Sectional Observational Study. [PDF]

Sensors (Basel)
Dragonieri S, Quaranta VN, Portacci A, Ranieri T, Carpagnano GE.   +4 more
europepmc   +1 more source

Assessment of Odour Emission During the Composting Process by Using Olfactory Methods and Gas Sensor Array Measurements. [PDF]

Sensors (Basel)
Szyłak-Szydłowski M, Kos W, Tarakowski R, Tkaczyk M, Borowik P.   +4 more
europepmc   +1 more source

Beyond the Lung. Impact of Elexacaftor/Tezacaftor/Ivacaftor on Sinonasal Disease in Children With Cystic Fibrosis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Elexacaftor/tezacaftor/ivacaftor (ETI) is a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) therapy that improves pulmonary function and chronic rhinosinusitis (CRS) in cystic fibrosis (CF) adults with at least one copy of the F508del CFTR mutation.
Margaux Petitjean, Alexia Letierce, Anne‐Sophie Bonnel, Philippe Reix, Eric Deneuville, Nathalie Stremler, Romain Luscan, Vincent Couloigner, Laurent Mely, Katia Bessaci, Guillaume Labbe, Christophe Marguet, Mairead Kelly‐Aubert, Fatiha Hassani, Isabelle Sermet‐Gaudelus, François Simon, the MODUL‐CF Study Group   +16 more
wiley   +1 more source

Internal Endpoint Cooking Temperature Alters Quality and Consumer Acceptability of Pork Loin Chops. [PDF]

Foods
Douglas SL, Barrazueta-Coredero RJ, Bernardez-Morales GM, Gilmore NE, Barahona-Dominguez LS, Cho S, Sawyer JT.   +6 more
europepmc   +1 more source

MiR‐221‐3p Attenuates IL‐33‐Induced Mast Cell Cytokine Expression by Targeting KIT

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Mast cells (MCs) are involved in type 2 inflammation in chronic rhinosinusitis with nasal polyps (CRSwNP), which depends on interleukin (IL)‐33 stimulation. MiR‐221 is reported to be an important regulator of MCs, and miR‐221‐3p can be expressed in CRSwNP. However, the role of miR‐221‐3p in CRSwNP is unclear. Methods Ethmoid tissues
Ruowu Liu, Jiao Zhou, Jing Zhou, Feng Liu, Yafeng Liu, Juan Meng, Luo Ba, Hengyi Xiao, Shixi Liu, Nan Zhang, Claus Bachert, Jintao Du   +11 more
wiley   +1 more source